concept

METABOLIC REPROGRAMMING

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about METABOLIC REPROGRAMMING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

62Connections
10Hypotheses
4Analyses
4Outgoing
13Incoming

No summary available yet. View on Wiki →

💡 Concept Info
NameMETABOLIC REPROGRAMMING
Key Genes/ProteinsAPP, LRP1, NLRP3, MTOR, PINK1
Related DiseasesINFLAMMATION, OXIDATIVE STRESS, ATP, MITOPHAGY
Linked Hypotheses10 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

primary-progressive-aphasia

disease · 7088 words

Corticobasal Degeneration (CBD)

disease · 5823 words

NPM1 Gene

gene · 5653 words

CBS/PSP Treatment Rankings

therapeutic · 5434 words

Pathway Diagram

graph TD
    METABOLIC_REPROGRAMMING["METABOLIC REPROGRAMMING"]
    METABOLIC_REPROGRAMMING -->|"mediates"| Cardiac_Aging["Cardiac Aging"]
    METABOLIC_REPROGRAMMING -->|"causes"| Gemcitabine_Resistance["Gemcitabine Resistance"]
    METABOLIC_REPROGRAMMING -->|"modulates"| Cardiac_Function["Cardiac Function"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Antibacterial_Defence["Antibacterial Defence"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Endothelial_Cell_Dysfunction["Endothelial Cell Dysfunction"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Sepsis_Associated_Acute_Kidney["Sepsis-Associated Acute Kidney Injury"]
    STAT3["STAT3"] -->|"regulates"| METABOLIC_REPROGRAMMING
    INFLAMMASOME["INFLAMMASOME"] -->|"causes"| METABOLIC_REPROGRAMMING
    HIF1A["HIF1A"] -->|"mediates"| METABOLIC_REPROGRAMMING
    PI3K_AKT_HIF1A["PI3K/AKT/HIF1A"] -->|"mediates"| METABOLIC_REPROGRAMMING
    TREM2["TREM2"] -->|"regulates"| METABOLIC_REPROGRAMMING
    PI3K_Akt_HIF1__Pathway["PI3K/Akt/HIF1alpha Pathway"] -->|"mediates"| METABOLIC_REPROGRAMMING
    ubiquitin_proteasome_system["ubiquitin-proteasome system"] -->|"modulates"| METABOLIC_REPROGRAMMING

Outgoing (26)

TargetRelationTypeStr
MICROGLIAactivatescell_type0.65
MICROGLIAimplicated_incell_type0.55
PI3K/AKT PATHWAYassociated_withpathway0.45
FINGOLIMODassociated_withdrug0.45

Incoming (36)

SourceRelationTypeStr
APPinhibitsgene0.65
APPcausesgene0.65
LRP1regulatesgene0.65
MACROPHAGESregulatescell_type0.65
NLRP3regulatesgene0.65

Targeting Hypotheses (10)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P 0.638 neurodegeneration Senolytic therapy for age-related neurod
Digital Twin-Guided Metabolic Reprogramming 0.605 neurodegeneration Digital biomarkers and AI-driven early d
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming 0.589 neurodegeneration Gene expression changes in aging mouse b
Disease-Associated Microglia Metabolic Reprogramming 0.502 neurodegeneration Cell type vulnerability in Alzheimers Di
Cell-Type Specific Metabolic Reprogramming 0.471 neurodegeneration Cell type vulnerability in Alzheimers Di
Astrocyte Metabolic Reprogramming via APOE4 Correction 0.451 neurodegeneration Cell type vulnerability in Alzheimer's D
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci 0.451 neurodegeneration CRISPR-based therapeutic approaches for
Oligodendrocyte Progenitor Cell Metabolic Reprogramming 0.410 neurodegeneration Which cell types show the most significa
Metabolic Reprogramming via Microglial Glycolysis Inhibition 0.385 neurodegeneration Synaptic pruning by microglia in early A
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem 0.376 neurodegeneration Selective vulnerability of entorhinal co

Mentioning Analyses (4)

Scientific analyses that reference this entity

Can metabolic interventions truly reverse established cellular senescence or onl

cell biology | 2026-04-08 | 0 hypotheses

How do astrocyte-neuron metabolic interactions change during disease progression

neurodegeneration | 2026-04-04 | 1 hypotheses Top: 0.506

Metabolic reprogramming in neurodegenerative disease

neurodegeneration | 2026-04-02 | 3 hypotheses Top: 0.398

Metabolic reprogramming in neurodegenerative disease

neurodegeneration | 2026-04-02 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Bergenin attenuates traumatic brain injury via inhibition of microglial PFKFB3-d [PMID:41520557] Sun B, Zhang A, Feng S, Jamali AW, Jia Z Int Immunopharmacol 2026 1
HK1 and HK2 Beyond Glycolysis: Mitochondrial Interactions and Dual Roles in Meta [PMID:41387352] Pesce NA, Seminara G, Giarrusso G, Tomas Adv Biol (Weinh) 2026 1
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative [PMID:39987285] Fang M, Zhou Y, He K, Lu Y, Tao F, Huang Mol Neurobiol 2025 1
Deficiency of Microglial Hv1 Protects Against Lipopolysaccharide-Induced Neuroin [PMID:40911376] Sun L, Wang X, Guan S, Zhang P, Chen D, FASEB J 2025 1
Metformin restores mitochondrial bioenergetics and redox homeostasis through mod [PMID:40327990] Brondani M, Ribeiro RT, Pinheiro CV, Hof Biomed Pharmacother 2025 1
System biology-based assessment of the molecular mechanism of epigallocatechin g [PMID:40664965] Fanai HL, Chand J, Ahmad SF, Attia SM, E Sci Rep 2025 1
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. [PMID:38904014] Fontana F, Giannitti G, Marchesi S, Limo Int J Biol Sci 2024 1
AST-120 alleviates renal ischemia-reperfusion injury by inhibiting HK2-mediated [PMID:39217289] Zhou J, Zhang J, Xu F, Gao H, Wang L, Zh Mol Med 2024 1
Hexokinase 2-mediated gene expression via histone lactylation is required for he [PMID:37463576] Rho H, Terry AR, Chronis C, Hay N Cell Metab 2023 1
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresista [PMID:36637036] Shigeta K, Hasegawa M, Hishiki T, Naito EMBO J 2023 1
Minutes of PPAR-γ agonism and neuroprotection. [PMID:32758586] Prashantha Kumar BR, Kumar AP, Jose JA, Neurochem Int 2020 1
Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydr [PMID:31131326] Tommasini-Ghelfi S, Murnan K, Kouri FM, Sci Adv 2019 1
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcino [PMID:28622513] Cancer Genome Atlas Research Network. El Cell 2017 1
Diagnostic, prognostic and predictive relevance of molecular markers in gliomas. [PMID:25944653] Brandner S, von Deimling A Neuropathol Appl Neurobiol 2015 1
The pharmacogenetics of type 2 diabetes: a systematic review. [PMID:24558078] Nisa M Maruthur, Matthew O Gribble, Wend Diabetes care 2014 1
IDH1 and IDH2 mutations in gliomas. [PMID:19228619] Yan H, Parsons DW, Jin G, McLendon R, Ra N Engl J Med 2009 1
Crosstalk Between [PMID:41899603] ["Ren Y", "Tang D", "Ding X", "He M"] Cancers 2026 0
Suoquan Yishen formula attenuates ectopic lipid deposition in diabetic kidney di [PMID:41461331] Wang J, Lin N, Li X, Ma T, Yuan Y et al. J Ethnopharmacol 2026 0
Yi-Shen-Hua-Shi granules ameliorate renal injury via PPARγ-Klotho-mediated metab [PMID:41475627] Gao HZ, Sun LM, Hu D, Li J, Chen CL et a J Ethnopharmacol 2026 0
Bisphenol A Promotes Ovarian Cancer Proliferation and Migration through the HK2/ [PMID:41885081] Xie X, Zhang Y, Li Y, Yan Q, Dong J et a J Agric Food Chem 2026 0